Figure 1. Kaplan-Meier estimation of overall survival rate in patients with brain metastases due to non-small-cell lung cancer treated with bevacizumab-gefitinib-WBRT, gefitinib-WBRT and WBRT. WBRT: whole brain radiotherapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.